These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 11171788)

  • 61. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction.
    Hayashi M; Tsutamoto T; Wada A; Tsutsui T; Ishii C; Ohno K; Fujii M; Taniguchi A; Hamatani T; Nozato Y; Kataoka K; Morigami N; Ohnishi M; Kinoshita M; Horie M
    Circulation; 2003 May; 107(20):2559-65. PubMed ID: 12732605
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of chronic nitrate therapy on left-ventricular volume in patients with heart failure secondary to coronary disease already treated with captopril: a withdrawal study.
    Wieshammer S; Hetzel M; Hetzel J; Henze E; Hombach V
    Cardiology; 2001; 95(2):61-5. PubMed ID: 11423708
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Early treatment of acute myocardial infarction with angiotensin-converting enzyme inhibition: safety considerations. SMILE pilot study working party.
    Ambrosioni E; Borghi C; Magnani B
    Am J Cardiol; 1991 Nov; 68(14):101D-110D. PubMed ID: 1746414
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Left ventricular remodeling after myocardial infarction: characterization of a swine model on beta-blocker therapy.
    Angeli FS; Shapiro M; Amabile N; Orcino G; Smith CS; Tacy T; Boyle AJ; Chatterjee K; Glantz SA; Grossman W; Yeghiazarians Y
    Comp Med; 2009 Jun; 59(3):272-9. PubMed ID: 19619418
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Effects of captopril on ischemia and dysfunction of the left ventricle after myocardial infarction.
    Søgaard P; Gøtzsche CO; Ravkilde J; Thygesen K
    Circulation; 1993 Apr; 87(4):1093-9. PubMed ID: 8462137
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [The effect of a combination ACE inhibitor and beta-blockers in acute myocardial infarct].
    Di Pasquale P; Paterna S
    G Ital Cardiol; 1999 Aug; 29(8):938-42. PubMed ID: 10488458
    [No Abstract]   [Full Text] [Related]  

  • 67. The effects of replacing beta-blockers with an angiotensin converting enzyme inhibitor on the quality of life of hypertensive patients.
    Paran E; Anson O; Neumann L
    Am J Hypertens; 1996 Dec; 9(12 Pt 1):1206-13. PubMed ID: 8972892
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Effect of long-term captopril therapy on left ventricular remodeling and function during healing of canine myocardial infarction.
    Jugdutt BI; Schwarz-Michorowski BL; Khan MI
    J Am Coll Cardiol; 1992 Mar; 19(3):713-21. PubMed ID: 1538033
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Captopril. A review of its pharmacology and therapeutic efficacy after myocardial infarction and in ischaemic heart disease.
    Plosker GL; McTavish D
    Drugs Aging; 1995 Sep; 7(3):226-53. PubMed ID: 8535052
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Effect of early metoprolol on infarct size in ST-segment-elevation myocardial infarction patients undergoing primary percutaneous coronary intervention: the Effect of Metoprolol in Cardioprotection During an Acute Myocardial Infarction (METOCARD-CNIC) trial.
    Ibanez B; Macaya C; Sánchez-Brunete V; Pizarro G; Fernández-Friera L; Mateos A; Fernández-Ortiz A; García-Ruiz JM; García-Álvarez A; Iñiguez A; Jiménez-Borreguero J; López-Romero P; Fernández-Jiménez R; Goicolea J; Ruiz-Mateos B; Bastante T; Arias M; Iglesias-Vázquez JA; Rodriguez MD; Escalera N; Acebal C; Cabrera JA; Valenciano J; Pérez de Prado A; Fernández-Campos MJ; Casado I; García-Rubira JC; García-Prieto J; Sanz-Rosa D; Cuellas C; Hernández-Antolín R; Albarrán A; Fernández-Vázquez F; de la Torre-Hernández JM; Pocock S; Sanz G; Fuster V
    Circulation; 2013 Oct; 128(14):1495-503. PubMed ID: 24002794
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Reduced cardiovascular morbidity and mortality in hypertensive diabetic patients on first-line therapy with an ACE inhibitor compared with a diuretic/beta-blocker-based treatment regimen: a subanalysis of the Captopril Prevention Project.
    Niskanen L; Hedner T; Hansson L; Lanke J; Niklason A;
    Diabetes Care; 2001 Dec; 24(12):2091-6. PubMed ID: 11723089
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Captopril in acute myocardial infarction. Beneficial effects on infarct size and arrhythmias.
    Bussmann WD; Micke G; Hildenbrand R; Klepzig H
    Presse Med; 1995 Feb; 24(7):345-50. PubMed ID: 7899404
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Cardiac protection by long-term treatment with captopril in patients with acute myocardial infarction.
    Shen W; Li M; Hu H; Zhang X; Gong L
    Chin Med J (Engl); 1998 Feb; 111(2):139-41. PubMed ID: 10374374
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Effect of prolonged beta-adrenergic blockade induced by atenolol on left ventricular remodeling after acute myocardial infarction in the rat.
    Shimada K; Nishikimi T; Kawarabayashi T; Takeuchi K; Takeda T
    Jpn Heart J; 1995 Jan; 36(1):81-9. PubMed ID: 7760516
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative efficacy of captopril and atenolol in moderately severe essential hypertension.
    Carey M; Blake S
    Postgrad Med J; 1986; 62 Suppl 1():111-2. PubMed ID: 3317338
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Molecular imaging for efficacy of pharmacologic intervention in myocardial remodeling.
    van den Borne SW; Isobe S; Zandbergen HR; Li P; Petrov A; Wong ND; Fujimoto S; Fujimoto A; Lovhaug D; Smits JF; Daemen MJ; Blankesteijn WM; Reutelingsperger C; Zannad F; Narula N; Vannan MA; Pitt B; Hofstra L; Narula J
    JACC Cardiovasc Imaging; 2009 Feb; 2(2):187-98. PubMed ID: 19356555
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effect of angiotensin-converting enzyme inhibitors on ventricular remodeling and survival following myocardial infarction.
    Beckwith C; Munger MA
    Ann Pharmacother; 1993 Jun; 27(6):755-66. PubMed ID: 8329800
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Is the reduction of the plasma levels of endothelin in the acute and sub-acute stage of myocardial infarct one of the beneficial effects of early treatment with ace inhibitors?].
    Di Pasquale P; Bucca V; Scalzo S; Cannizzaro S; Longo AM; Alessi V; D'Amato M; Manusia F; Magatti MF
    G Ital Cardiol; 1996 Jun; 26(6):673-80. PubMed ID: 8803588
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Attenuation of adenosine-induced myocardial perfusion heterogeneity by atenolol and other cardioselective beta-adrenoceptor blockers: a crossover myocardial perfusion imaging study.
    Reyes E; Stirrup J; Roughton M; D'Souza S; Underwood SR; Anagnostopoulos C
    J Nucl Med; 2010 Jul; 51(7):1036-43. PubMed ID: 20554740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.